Sharon Bio-Medicine is currently trading at Rs. 30.10, up by 0.30 points or 1.01% from its previous closing of Rs. 29.80 on the BSE.
The scrip opened at Rs. 30.50 and has touched a high and low of Rs. 31.70 and Rs. 29.80 respectively. So far 1,90,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 44.30 on 17-Dec-2014 and a 52 week low of Rs. 12.45 on 06-Jul-2015.
Last one week high and low of the scrip stood at Rs. 32.55 and Rs. 28.30 respectively. The current market cap of the company is Rs. 325.00 crore.
The promoters holding in the company stood at 59.51% while Institutions and Non-Institutions held 5.24% and 35.25% respectively.
Sharon Bio-Medicine’s division - Sanctuary for Research & Development (SA-FORD) which is actively practicing Clinical Research Studies has cleared National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA) Surveillance Inspection. The laboratory of SA-FORD is located at MIDC, Taloja.
Now, SA-FORO had included Physio-Chemical Testing including Five Batch Analysis under the scope of Organization for Economic Co-operation & Development (OECD) under the principles of GLP.
Sharon Bio-Medicine is into manufacturing and supply of Active Pharmaceutical Ingredients (APIs).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |